ES2173054T3 - Base cristalina de citalopram. - Google Patents

Base cristalina de citalopram.

Info

Publication number
ES2173054T3
ES2173054T3 ES01909568T ES01909568T ES2173054T3 ES 2173054 T3 ES2173054 T3 ES 2173054T3 ES 01909568 T ES01909568 T ES 01909568T ES 01909568 T ES01909568 T ES 01909568T ES 2173054 T3 ES2173054 T3 ES 2173054T3
Authority
ES
Spain
Prior art keywords
citalopram
crystal base
base
precipitated
transformed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES01909568T
Other languages
English (en)
Other versions
ES2173054T1 (es
Inventor
Hans Petersen
Klaus Peter Boegesoe
Per Holm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8159320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2173054(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of ES2173054T1 publication Critical patent/ES2173054T1/es
Application granted granted Critical
Publication of ES2173054T3 publication Critical patent/ES2173054T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Laminated Bodies (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

Un procedimiento para la preparación de una sal de citalopram, caracterizado porque la base de citalopram se pone en libertad y se precipita en forma cristalina, opcionalmente se recristaliza una o más veces y luego se transforma en una de sus sales.
ES01909568T 2000-03-13 2001-02-28 Base cristalina de citalopram. Expired - Lifetime ES2173054T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000402 2000-03-13
DKPCT/DK00/00183 2000-04-13

Publications (2)

Publication Number Publication Date
ES2173054T1 ES2173054T1 (es) 2002-10-16
ES2173054T3 true ES2173054T3 (es) 2002-12-16

Family

ID=8159320

Family Applications (3)

Application Number Title Priority Date Filing Date
ES01909568T Expired - Lifetime ES2173054T3 (es) 2000-03-13 2001-02-28 Base cristalina de citalopram.
ES02009350T Expired - Lifetime ES2180471T3 (es) 2000-03-13 2001-02-28 Base cristalina de citalopram y su sal hidrocloruro o hidrobromuro.
ES200100548A Expired - Fee Related ES2159491B1 (es) 2000-03-13 2001-03-09 Base cristalina de citalopram

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES02009350T Expired - Lifetime ES2180471T3 (es) 2000-03-13 2001-02-28 Base cristalina de citalopram y su sal hidrocloruro o hidrobromuro.
ES200100548A Expired - Fee Related ES2159491B1 (es) 2000-03-13 2001-03-09 Base cristalina de citalopram

Country Status (42)

Country Link
US (7) US20010031784A1 (es)
EP (2) EP1227088B1 (es)
JP (1) JP2003527383A (es)
KR (1) KR20020080486A (es)
CN (2) CN1680350A (es)
AR (1) AR029811A1 (es)
AT (3) ATE223396T1 (es)
AU (2) AU746664B2 (es)
BE (1) BE1013210A3 (es)
BG (1) BG107065A (es)
BR (1) BR0109373A (es)
CA (2) CA2411732A1 (es)
CH (2) CH691537A5 (es)
CZ (1) CZ292077B6 (es)
DE (7) DE20007303U1 (es)
DK (3) DK173903B1 (es)
EA (1) EA200200972A1 (es)
ES (3) ES2173054T3 (es)
FI (2) FI20010156A0 (es)
FR (1) FR2806086B1 (es)
GB (2) GB2357762B (es)
GR (1) GR1003796B (es)
HK (1) HK1054750A1 (es)
HR (1) HRP20020756A2 (es)
HU (3) HU0001581D0 (es)
IE (1) IES20010109A2 (es)
IL (2) IL158072A0 (es)
IS (1) IS5841A (es)
IT (2) IT1319645B1 (es)
MX (1) MXPA02008793A (es)
NL (2) NL1016435C1 (es)
NO (2) NO312031B1 (es)
PL (1) PL360158A1 (es)
PT (2) PT1227088E (es)
SE (2) SE517136C2 (es)
SI (2) SI1227088T1 (es)
SK (1) SK285528B6 (es)
TR (1) TR200202185T2 (es)
UA (1) UA74360C2 (es)
WO (1) WO2001068627A1 (es)
YU (1) YU68802A (es)
ZA (1) ZA200207148B (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004033B1 (ru) 1999-04-14 2003-12-25 Х.Лундбекк А/С Способ получения циталопрама
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US8328829B2 (en) 1999-08-19 2012-12-11 Covidien Lp High capacity debulking catheter with razor edge cutting window
US7708749B2 (en) 2000-12-20 2010-05-04 Fox Hollow Technologies, Inc. Debulking catheters and methods
US7713279B2 (en) 2000-12-20 2010-05-11 Fox Hollow Technologies, Inc. Method and devices for cutting tissue
US6299622B1 (en) 1999-08-19 2001-10-09 Fox Hollow Technologies, Inc. Atherectomy catheter with aligned imager
US7887556B2 (en) 2000-12-20 2011-02-15 Fox Hollow Technologies, Inc. Debulking catheters and methods
IES20010157A2 (en) 2000-03-03 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
IES20010206A2 (en) 2000-03-13 2002-03-06 Lundbeck & Co As H Method for the preparation of citalopram
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
AR032455A1 (es) 2000-05-12 2003-11-12 Lundbeck & Co As H Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram
GB2376233B (en) * 2000-08-10 2003-09-10 Lundbeck & Co As H Crystals of a pharmaceutically acceptable salt of citalopram wherein the median size of the crystals is at least 40 microns
EP2353526B1 (en) 2000-12-20 2013-09-04 Covidien LP Catheter for removing atheromatous or thrombotic occlusive material
TR200201166T1 (tr) * 2000-12-22 2002-10-21 H.Lundbecks A/S Saf sitalopram hazırlanması için yöntem
AU2001100195B4 (en) * 2001-01-05 2001-12-20 H Lundbeck As Pharmaceutical composition containing citalopram.
GB0105627D0 (en) * 2001-03-07 2001-04-25 Cipla Ltd Preparation of phthalanes
CA2445843A1 (en) * 2001-05-01 2002-11-07 H. Lundbeck A/S The use of enantiomeric pure escitalopram
TR200400189T2 (tr) 2001-07-31 2004-12-21 H.Lundbeck A/S Esitalopram içeren kristal yapılı bileşim.
US7148364B2 (en) * 2002-01-07 2006-12-12 Sun Pharmaceutical Industries Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
GB0204607D0 (en) * 2002-02-27 2002-04-10 Matrix Lab Ltd Process
GB2386119A (en) * 2002-02-27 2003-09-10 Cipla Ltd Purification of citalopram
GB2386118A (en) * 2002-02-27 2003-09-10 Cipla Ltd Citalopram
GB2387596B (en) * 2002-02-27 2004-02-11 Matrix Lab Ltd Process
GB2385848A (en) * 2002-02-27 2003-09-03 Cipla Ltd Citalopram salts
EP1346989A1 (en) * 2002-03-21 2003-09-24 Jubilant Organosys Limited Improved process for the preparation of citalopram and its hydrobromide
GB0206708D0 (en) * 2002-03-21 2002-05-01 Cipla Ltd Pharmaceutical salts
US6812355B2 (en) 2002-10-22 2004-11-02 Sekhsaria Chemicals Limited Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
AU2003223105A1 (en) * 2003-03-24 2004-10-18 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
AU2003238676A1 (en) * 2003-04-21 2004-11-19 Podile Khadgapathi An improved process for the preparation of citalopram hydrobromide
US8246640B2 (en) 2003-04-22 2012-08-21 Tyco Healthcare Group Lp Methods and devices for cutting tissue at a vascular location
EP1486492A3 (en) * 2003-06-10 2005-02-23 Sun Pharmaceuticals Industries Ltd. A process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran.
GB0317475D0 (en) 2003-07-25 2003-08-27 Meditab Specialities Pvt Ltd Product
JP4025735B2 (ja) * 2003-08-21 2007-12-26 ローム アンド ハース カンパニー 水性系を処理する方法
GB0320312D0 (en) 2003-08-29 2003-10-01 Novartis Ag Purification process
CN100569765C (zh) * 2003-12-19 2009-12-16 杭州民生药业集团有限公司 西酞普兰中间体晶体碱
ITTO20050301A1 (it) * 2005-05-05 2006-11-06 Errekappa Euroterapici Spa Formulazioni liquide orali contenenti citalopram
US20110196032A1 (en) * 2005-05-20 2011-08-11 Ashish Gogia Pharmaceutical Dosage Form of an Antidepressant
TWI347942B (en) * 2005-06-22 2011-09-01 Lundbeck & Co As H Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
NZ561375A (en) 2005-06-27 2011-06-30 Biovail Lab Int Srl Bupropion hydrobromide, and crystalline forms, compositions, and uses of this compound
US20070276419A1 (en) 2006-05-26 2007-11-29 Fox Hollow Technologies, Inc. Methods and devices for rotating an active element and an energy emitter on a catheter
US8784440B2 (en) 2008-02-25 2014-07-22 Covidien Lp Methods and devices for cutting tissue
WO2010045226A2 (en) 2008-10-13 2010-04-22 Fox Hollow Technologies, Inc. Devices and methods for manipulating a catheter shaft
ES2532407T3 (es) 2009-04-29 2015-03-26 Covidien Lp Dispositivos para cortar y raspar tejido
BRPI1010595A2 (pt) 2009-05-14 2017-05-16 Tyco Healthcare cateteres de aterectomia facilmente limpaveis e metodos para uso
EP2913013B1 (en) 2009-12-02 2016-11-09 Covidien LP Methods and devices for cutting tissue
CA2783301C (en) 2009-12-11 2015-02-24 Tyco Healthcare Group Lp Material removal device having improved material capture efficiency and methods of use
KR101493138B1 (ko) 2010-06-14 2015-02-12 코비디엔 엘피 물질 제거 장치
US8920450B2 (en) 2010-10-28 2014-12-30 Covidien Lp Material removal device and method of use
RU2553930C2 (ru) 2010-11-11 2015-06-20 Ковидиен Лп Гибкие фрагментирующие катетеры с визуализацией и способы их использования и изготовления
JP5806407B2 (ja) 2011-09-01 2015-11-10 コヴィディエン リミテッド パートナーシップ 螺旋駆動軸を有するカテーテルおよび製造方法
US9579157B2 (en) 2012-09-13 2017-02-28 Covidien Lp Cleaning device for medical instrument and method of use
US9943329B2 (en) 2012-11-08 2018-04-17 Covidien Lp Tissue-removing catheter with rotatable cutter
WO2015200702A1 (en) 2014-06-27 2015-12-30 Covidien Lp Cleaning device for catheter and catheter including the same
US10314667B2 (en) 2015-03-25 2019-06-11 Covidien Lp Cleaning device for cleaning medical instrument
US10292721B2 (en) 2015-07-20 2019-05-21 Covidien Lp Tissue-removing catheter including movable distal tip
US10314664B2 (en) 2015-10-07 2019-06-11 Covidien Lp Tissue-removing catheter and tissue-removing element with depth stop
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2233970A (en) * 1941-03-04 Quinoline compound and process of
US2584429A (en) * 1950-12-29 1952-02-05 Rohm & Haas 1,1-diphenyl-4-tert.-amino-2-butyne-1-ols
GB1143702A (es) * 1965-03-18
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
DK213290D0 (da) 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
CA2120874E (en) * 1994-04-08 2002-01-08 Keshava Murthy Form of form 1 ranitidine
DE69801764T2 (de) * 1997-07-08 2002-07-04 Lundbeck & Co As H Verfahren zur herstellung von citalopram
UA62985C2 (en) * 1997-11-10 2004-01-15 Lunnbeck As H A method for the preparation of citalopram
DE69714480T2 (de) * 1997-11-11 2003-03-06 Lundbeck & Co As H Verfahren zur Herstellung von Citalopram
PL199423B1 (pl) 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
EA004033B1 (ru) 1999-04-14 2003-12-25 Х.Лундбекк А/С Способ получения циталопрама
ITMI991579A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
ITMI991581A1 (it) 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
US6433196B1 (en) * 2000-02-17 2002-08-13 Sumika Fine Chemicals Co., Ltd. Production method of citalopram, intermediate therefor and production method of the intermediate
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof

Also Published As

Publication number Publication date
ATE250050T1 (de) 2003-10-15
FR2806086A1 (fr) 2001-09-14
BG107065A (bg) 2003-05-30
SK13132002A3 (sk) 2003-01-09
US20050165244A1 (en) 2005-07-28
US20010031784A1 (en) 2001-10-18
AU746664B2 (en) 2002-05-02
HU0100450D0 (en) 2001-04-28
BR0109373A (pt) 2002-12-24
IL147339A (en) 2004-09-27
HU0100531D0 (en) 2001-03-28
NL1016435C1 (nl) 2000-11-06
IS5841A (is) 2001-09-14
NO20020356D0 (no) 2002-01-23
GB2357762A (en) 2001-07-04
DK1227088T3 (da) 2003-12-22
DE60100022T3 (de) 2011-11-17
SE517136C2 (sv) 2002-04-16
AU2001100197B4 (en) 2001-12-06
CH691537A5 (de) 2001-08-15
BE1013210A3 (fr) 2001-10-02
CZ2001808A3 (cs) 2002-01-16
TR200202185T2 (tr) 2002-12-23
DE60100786T2 (de) 2004-07-15
DE20121240U1 (de) 2002-07-04
ES2173054T1 (es) 2002-10-16
SI1227088T1 (en) 2003-12-31
AU2001100197A4 (en) 2001-09-20
GB2357762B (en) 2002-01-30
NO20010619L (no) 2001-09-14
ZA200207148B (en) 2003-04-23
IL158072A0 (en) 2004-03-28
ATE223396T1 (de) 2002-09-15
EP1169314B1 (en) 2002-09-04
FR2806086B1 (fr) 2003-05-09
KR20020080486A (ko) 2002-10-23
HUP0100531A2 (hu) 2002-01-28
EP1169314B2 (en) 2011-06-01
CZ292077B6 (cs) 2003-07-16
GR1003796B (el) 2002-02-08
AR029811A1 (es) 2003-07-16
SI1169314T1 (en) 2002-12-31
SI1169314T2 (sl) 2011-08-31
US20050165092A1 (en) 2005-07-28
FI20010225A0 (fi) 2001-02-07
GB0105982D0 (en) 2001-05-02
MXPA02008793A (es) 2003-02-12
SE0200730D0 (sv) 2002-03-12
UA74360C2 (uk) 2005-12-15
CA2411732A1 (en) 2001-09-20
DE60100022D1 (de) 2002-10-10
EP1169314A1 (en) 2002-01-09
FI20010225A (fi) 2001-09-14
SE0200730L (sv) 2002-08-29
PL360158A1 (en) 2004-09-06
DE60100022T2 (de) 2003-03-06
GB0102797D0 (en) 2001-03-21
CA2360287A1 (en) 2001-09-20
US20060247451A1 (en) 2006-11-02
US20040132808A1 (en) 2004-07-08
ES2159491A1 (es) 2001-10-01
ITMI20010406A1 (it) 2002-08-28
NO315851B1 (no) 2003-11-03
WO2001068627A1 (en) 2001-09-20
ITMI20002425A1 (it) 2002-05-09
PT1169314E (pt) 2002-11-29
SE0103046L (sv) 2001-11-14
CH691477A5 (de) 2001-07-31
CN1680350A (zh) 2005-10-12
DE10108042A1 (de) 2001-10-18
IES20010109A2 (en) 2002-02-20
US20030078442A1 (en) 2003-04-24
AT4364U1 (de) 2001-06-25
EA200200972A1 (ru) 2003-02-27
EP1227088A1 (en) 2002-07-31
SE0103046D0 (sv) 2001-09-14
CN1429220A (zh) 2003-07-09
US20040167210A1 (en) 2004-08-26
DK173903B1 (da) 2002-02-11
CA2360287C (en) 2003-09-09
DE20007303U1 (de) 2000-07-27
HRP20020756A2 (en) 2004-12-31
FI20010156A0 (fi) 2001-01-25
ES2180471T1 (es) 2003-02-16
NO20020356L (no) 2001-09-14
AU3725201A (en) 2001-09-13
FI109022B (fi) 2002-05-15
DE1227088T1 (de) 2003-02-06
DK1169314T3 (da) 2002-10-14
IL147339A0 (en) 2002-08-14
ES2180471T3 (es) 2004-05-01
IT1319645B1 (it) 2003-10-23
ES2159491B1 (es) 2002-05-01
SK285528B6 (sk) 2007-03-01
HU0001581D0 (en) 2000-06-28
JP2003527383A (ja) 2003-09-16
CN1258530C (zh) 2006-06-07
PT1227088E (pt) 2003-12-31
HUP0100531A3 (en) 2004-04-28
YU68802A (sh) 2005-11-28
NL1017413C1 (nl) 2001-09-13
HK1054750A1 (en) 2003-12-12
SE526022C2 (sv) 2005-06-14
NO312031B1 (no) 2002-03-04
NO20010619D0 (no) 2001-02-06
EP1227088B1 (en) 2003-09-17
DE60100786D1 (de) 2003-10-23
DE10164687B4 (de) 2006-04-27

Similar Documents

Publication Publication Date Title
ES2173054T3 (es) Base cristalina de citalopram.
DE60101870D1 (de) Fälschungssicheres Aufzeichnungspapier und Papierträger
ATE258918T1 (de) Kristallform alpha des perindopril-tert- butylaminsalzes
DE60035378D1 (de) Gerät zur Behandlung von Bandscheiben
CY2012028I2 (el) Η χρηση δαποξετινης, ενος ταχειας-εναρξης επιλεκτικου αναστολεα εκ νεου αναληψης σepοτονινης για την θepαπευτικη αντιμετωπιση σεξουαλικης δυσλειτουργιας
AR026592A1 (es) Un dispositivo para la propagacion y almacenamiento de microorganismos
IS6759A (is) Ný þíadíasól og oxadíasól og notkun þeirra sem fosfórdíesterasa-7 hindra
ITMI20011386A0 (it) Gemma ornamentale
CY2009001I1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
AR022706A1 (es) Una cama para personas en estado de postracion permanente.
DK1255754T3 (da) Linezolid-krystalform II
UY26454A1 (es) Cristal de 4-carboxamino-1,2,3,4-tetrahidroquinolina 2-sustituida
NO20031417L (no) Fischer-Tropsch prosess
ATE322492T1 (de) Nicht-nukleosid reverse transkriptase inhibitoren
DE60107074D1 (de) Kristallin form ii von cabergolin
DE50115204D1 (de) Anlage zum formbearbeiten der ränder von brillengläsern
NO20030243D0 (no) Nye forbindelser og deres anvendelse som glysintransportinhibitorer
ITBO20000119V0 (it) Ciondolo portachiavi
NO20002067D0 (no) Fremgangsmõte for generering av varme og kraft samt anvendelse derav
BR0110206A (pt) Inibidores de peptìdeo deformilase
UY26556A1 (es) Compuestos calcilíticos
DE60106850D1 (de) Wälzschleifen von nichtmetallischen Zahnrädern
HN2001000036A (es) Nueva forma de sal y polimorfos
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
IS7218A (is) Notkun rósúvastatíns á forstigi vitglapa